Skip to main content
The Tri-State Experience: Outcome Analysis of Patients with Triple Negative Breast Cancer Treated at Marshall University
Internal Medicine
  • Laurie Matt, MD, MPH, Marshall University
  • Mohammad Mozayen, MD, Marshall University
  • Todd W. Gress, MD, Marshall University
  • Maria Tria Tirona, MD, Marshall Univerisity
Document Type
Publication Date
Breast cancer is the most frequently diagnosed malignancy in women in the United States. It is the second most common malignancy to cause death, with approximately 39,000 women dying of breast cancer in the United States in 2013. Triple negative breast cancer is defined as the absence of estrogen, progesterone and human epidermal growth factor receptor 2 receptors. It has been associated with a higher incidence in African American women, a younger age and a more advanced stage at diagnosis, and an inferior overall survival. To recognize the differences of our West Virginia community population when compared to the national average, we conducted a retrospective review of all patients diagnosed with breast cancer from 2000-2012.

The copy of record is available from the publisher at Copyright © 2014 West Virginia State Medical Association. Reprinted with permission. All rights reserved.

Citation Information
Matt L, Mozayen M, Gress T, Tirona MT. The Tri-State experience: Outcome analysis of patients with triple negative breast cancer treated at Marshall University. West Virginia Medical Journal. 2015;111(5):30-5.